Target intelligence / Profile preview

Biogenesis of lysosomal organelles complex 3 subunit 1 (HPS1)

Target
HPS1
Molecular classification
Other (subunit of BLOC-3 protein complex), Guanine nucleotide exchange factor (GEF) subunit, Organelle biogenesis regulator
01

Overview

Biogenesis of lysosomal organelles complex 3 subunit 1 (HPS1) is a protein encoded by the *HPS1* gene that forms a core component of the BLOC-3 complex, together with HPS4. BLOC-3 is crucial for the formation, maturation, and trafficking of lysosome-related organelles (LROs), including melanosomes (involved in pigmentation) and platelet dense granules (important for blood clotting). HPS1 acts as part of a guanine nucleotide exchange factor (GEF) complex that activates Rab32 and Rab38 small GTPases, orchestrating the delivery and recycling of vesicular components necessary for specialized organelle function. Mutations in *HPS1* are the most common cause of Hermansky-Pudlak syndrome, an autosomal recessive disorder manifesting with albinism, bleeding tendency, and variable chronic organ involvement such as pulmonary fibrosis and inflammatory bowel disease. BLOC-3 assembly and its interaction with Rab GTPases are essential for proper pigmentation, immune responses, and secretory vesicle maturation. There are no known drugs that directly target HPS1; its variants serve as disease biomarkers for genetics-based diagnosis.

Other names
BLOC-3 complex member HPS1HPS1HPSBLOC3S1Hermansky-Pudlak syndrome 1 protein
02

Mechanism of action

Not applicable; HPS1 itself is not targeted by drugs, but disruption/mutation leads to disease

03

Biological functions

Biogenesis of lysosome-related organelles (LROs) including melanosomes and platelet-dense granulesIntracellular protein trafficking and organelle localizationRegulation of vesicle trafficking via GTPase activation (Rab32, Rab38, Rab9A)Maturation of specialized secretory vesicles (e.g., large dense core vesicles in Paneth cells)Possible role in immune response against intracellular pathogens
04

Disease associations

Hermansky-Pudlak syndrome (HPS)Inflammatory bowel disease (HPS-associated IBD)Pigmentation disorders (oculocutaneous albinism)Bleeding disorders (platelet dysfunction)
05

Safety considerations

Mutation leads to multi-organ dysfunction: pigmentation, bleeding, lung fibrosis, bowel inflammationRisk of bleeding due to platelet granule defectsIncreased susceptibility to chronic organ pathologies and inflammatory bowel complications
06

Interacting drugs

None known; HPS1 is not a current direct pharmacological target
07

Biomarkers

HPS1 variants/mutations as diagnostic markers for Hermansky-Pudlak syndrome

Beyond the preview

Go deeper on Biogenesis of lysosomal organelles complex 3 subunit 1 (HPS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biogenesis of lysosomal organelles complex 3 subunit 1 (HPS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call